Clindets Related Published Studies
Well-designed clinical trials related to Clindets (Clindamycin Topical)
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations. [2009.08]
Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. [2009.05]
Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel. [2009.04]
Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability. [2009.03]
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. [2008.11]
A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring. [2008.08]
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. [2007.07]
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. [2007.06]
Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study. [2006.11]
Bioequivalence study of clindamycin phosphate injection (Clinott-P) in Thai healthy volunteers. [2006.05]
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. [2006.03]
A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne. [2006]
An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. [2005.12]
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. [2005.09]
Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris. [2005.07]
Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination. [2005.03]
A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. [2005.01]
The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. [2005.01]
A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. [2004.12]
Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea. [2004.06]
Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea. [2004.05]
Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. [2003.09]
A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. [2002.07]
Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. [2002.06]
Clindamycin phosphate 1% gel in acne vulgaris. [2001.11]
Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. [2001.10]
A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. [2001.02]
The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. [2001.01]
Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. [2001]
A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris. [2000.09]
Potential patient preference for 3-day treatment of bacterial vaginosis: responses to new suppository form of clindamycin. [2000.05]
Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. [2000.05]
The effect of oral decontamination with clindamycin palmitate on the incidence of bacteremia after esophageal dilation: a prospective trial. [1999.10]
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. [1998.12]
Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. [1998.11]
Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. [1997.10]
High-performance liquid chromatographic determination of clindamycin in human plasma or serum: application to the bioequivalency study of clindamycin phosphate injections. [1997.08.29]
[Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin] [1997.05]
Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. [1995.06]
Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin. [1994.11]
Efficacy of topical amoxicillin plus clavulanate/ticarcillin plus clavulanate and clindamycin in contaminated head and neck surgery: effect of antibiotic spectra and duration of therapy. [1994.09]
Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. [1994.04]
Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. [1993.09]
Treatment of rosacea: topical clindamycin versus oral tetracycline. [1993.01]
The effects of topical oral clindamycin antibiotic rinses on the bacterial content of saliva on healthy human subjects. [1991.12]
Bacterial vaginosis: diagnostic and pathogenetic findings during topical clindamycin therapy. [1990.08]
Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate. [1990.07]
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. [1990.03]
A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris. [1990]
[Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin] [1989]
A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris. [1988.11]
Well-designed clinical trials possibly related to Clindets (Clindamycin Topical)
Comparative efficacy and safety results of two topical combination acne regimens. [2009.07]
Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne. [2008.03]
Pilot investigation of the hydrating effects of topical acne medications. [2007.08]
Clinical and Microbiological Comparisons of Isotretinoin vs. Tetracycline in Acne Vulgaris. [2007]
Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial. [2006.03]
The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis. [2005.09]
Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-masked, randomized, controlled multicenter study. II. Microbiological results. [2005.01]
Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. [2005.01]
[Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies] [2004.10]
Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. [2003.09]
New therapy update--A unique combination formulation in the treatment of inflammatory acne. [2003.07]
Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents. [2001.07]
Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: a prospective, double-masked randomized pilot study. [2001]
Effect of topical antibiotic therapy on recovery after tonsillectomy in adults. [1999.09]
Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. [1997.06]
Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora. [1996.11]
Fluorescence photography in the evaluation of acne. [1996.07]
Combined topical and systemic antibiotic prophylaxis in acute appendicitis. [1990.02]
A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris. [1988.09]
Topical antibiotics in the high-risk biliary surgical patient. A prospective, randomized study. [1988.02]
Other research related to Clindets (Clindamycin Topical)
Topical clindamycin in post-adenotonsillectomy analgesia in children: A double-blind, randomized clinical trial. [2009.10]
Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate. [2009.07]
The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. [2009.07]
Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial. [2009.05]
Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. [2009.05]
[Management of acne vulgaris: focus on clindamycin and zinc] [2009.01]
Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. [2008.11]
Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study. [2008.11]
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. [2008.05]
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. [2008.01]
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne. [2008]
Topical clindamycin in the management of acne vulgaris. [2007.10]
Clindamycin and taste disorders. [2007.10]
Adapalene pretreatment increases follicular penetration of clindamycin: in vitro and in vivo studies. [2007.09]
Lethal drug probe in China: the case of Xinfu clindamycin. [2007.08]
Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1-butanol microemulsions. [2007.08]
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. [2007.07.13]
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. [2007.06]
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. [2007.03]
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. [2006.02]
Intraosseous injection of clindamycin phosphate into the chronic apical lesion of lower molar--a case report. [2005.05]
An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. [2005]
Simultaneous determination of tretinoin and clindamycin phosphate and their degradation products in topical formulations by reverse phase HPLC. [2004.01]
Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne. [2002.10]
A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin. [2002.09]
Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. [2002.09]
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. [2002]
Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction. [2001.02]
Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. [2001.02]
The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study. [2001]
|
